Home › Follicular Lymphoma
Pag-aaral pangklinika para sa Follicular Lymphoma na nagre-recruit sa U.S.
106 pag-aaral para sa Follicular Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY24 pag-aaral
- Houston, TX20 pag-aaral
- Milwaukee, WI19 pag-aaral
- Nashville, TN18 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Seattle, WA16 pag-aaral
- Boston, MA16 pag-aaral
- Durham, NC16 pag-aaral
- Salt Lake City, UT13 pag-aaral
- Columbus, OH13 pag-aaral
- Los Angeles, CA13 pag-aaral
- Chicago, IL12 pag-aaral
- San Antonio, TX12 pag-aaral
- Philadelphia, PA12 pag-aaral
- Denver, CO11 pag-aaral
- Cleveland, OH11 pag-aaral
- Dallas, TX11 pag-aaral
- Edison, NJ11 pag-aaral
- Washington, DC11 pag-aaral
- Atlanta, GA11 pag-aaral
- Jacksonville, FL10 pag-aaral
- Rochester, MN10 pag-aaral
- Portland, OR9 pag-aaral
- New Haven, CT9 pag-aaral
- Cincinnati, OH9 pag-aaral
- Tampa, FL8 pag-aaral
- Pittsburgh, PA8 pag-aaral
- San Diego, CA8 pag-aaral
- Miami, FL8 pag-aaral
- San Francisco, CA8 pag-aaral
- Charlotte, NC7 pag-aaral
- Mountain View, CA7 pag-aaral
- Queens, NY7 pag-aaral
- Clifton, NJ7 pag-aaral
- Cedar Rapids, IA7 pag-aaral
- Austin, TX6 pag-aaral
- Richmond, VA6 pag-aaral
- Greenburgh, NY6 pag-aaral
- St. Louis, MO6 pag-aaral
- Winston-Salem, NC6 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona12 pag-aaral
- Arkansas3 pag-aaral
- California36 pag-aaral
- Colorado15 pag-aaral
- Connecticut10 pag-aaral
- Delaware4 pag-aaral
- District of Columbia4 pag-aaral
- Florida25 pag-aaral
- Georgia15 pag-aaral
- Illinois14 pag-aaral
- Indiana7 pag-aaral
- Iowa9 pag-aaral
- Kansas7 pag-aaral
- Kentucky10 pag-aaral
- Louisiana8 pag-aaral
- Maryland9 pag-aaral
- Massachusetts19 pag-aaral
- Michigan12 pag-aaral
- Minnesota17 pag-aaral
- Mississippi4 pag-aaral
- Missouri8 pag-aaral
- Nebraska4 pag-aaral
- New Jersey15 pag-aaral
- New Mexico3 pag-aaral
- New York30 pag-aaral
- North Carolina25 pag-aaral
- Ohio25 pag-aaral
- Oklahoma4 pag-aaral
- Oregon11 pag-aaral
- Pennsylvania17 pag-aaral
- Rhode Island4 pag-aaral
- South Carolina6 pag-aaral
- Tennessee19 pag-aaral
- Texas37 pag-aaral
- Utah13 pag-aaral
- Virginia11 pag-aaral
- Washington20 pag-aaral
- Wisconsin21 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07519772A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT03460977A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07634471A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma and Marginal Zone Lymphoma Not Accomplishing a Complete Response With Upfront Therapy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06510361A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06091254A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06149286Clonal Evolution in Follicular Lymphoma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT03190928A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07101328Auto Stem Cell Transplant for Lymphoma Patients
Nagre-recruitPhase 2
Hanggang edad 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT03125642A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07226843Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07215910rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
Nagre-recruit
Edad 22 hanggang 65 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT05974202A Study of ARC-02 in B-cell NHL
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07691606Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Nob 2, 2026 · NCT07167862A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Nagre-recruitPhase 1
Edad 4 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT04573140Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05765812Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01137643Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06108232Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07029217Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT04545762Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Nagre-recruitPhase 2
Edad 3 hanggang 31 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT02393157A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07546760Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06815029Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.